Prophylactic antiemetic efficacy of granisetron or ramosetron in patients undergoing thyroidectomy

Asian Journal of Surgery

Volumn 25, Issue 4, 2002, Pages 309-314

  Lee, S Y ^a   Lee, J Y ^b   Park, S Y ^a   Kim, J H ^a   Cho, O G ^a   Kim, J S ^a   Soh, E Y ^a  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; GRANISETRON; METOCLOPRAMIDE; PLACEBO; RAMOSETRON;

ADULT; AGED; ANESTHESIA; ANESTHESIA INDUCTION; ANTIEMETIC ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; POSTOPERATIVE PERIOD; PROPHYLAXIS; RANDOMIZATION; THYROIDECTOMY; VERTIGO; VOMITING;

EID: 0036815488     PISSN: 10159584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1015-9584(09)60197-4     Document Type: Conference Paper

References (28)

1. Rowbotham DJ, Smith G. Introduction to supplement on postoperative nausea and vomiting. Br J Anaesth 1992;69(1 Suppl):S1.
2. Tramer MR, Reynolds DJM, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting. Anesthesiology 1997;87:1277-89.
3. Dejonckheere M, Deloof T, Dustin N, Ewalenko P. Alizapride in the prevention of post-thyroidectomy emetic sequelae. Eur J Anaesth 1990;7:417-21.
4. Ewalenko P, Janny S, Dejonckheere M, et al. Antiemetic effects of subhypnotic doses of propofol after thyroidectomy. Br J Anaesth 1996;77:463-7.
5. Fujihara A, Akuzawa S, Miyata K, Miyake A. Ramosetron hydrochloride: affinity for cloned human 5-HT3 receptor antagonistic and antiemetic effect in the ferret. (Japanese). Lab Clin 1996;30:1965-72.
6. Fujii T, Tanaka H, Toyooka H. Effective dose of granisetron in the reduction of nausea and vomiting after breast surgery. Acta Anaesthesiol Scand 1997;41:1167-70.
7. Fujii Y, Toyooka H, Tanaka H. Granisetron reduces the incidence of nausea and vomiting following middle ear surgery. Br J Anaesth 1997;79:539-40.
8. Fujii Y, Toyooka H, Tanaka H. Granisetron in the prevention of nausea and vomiting after middle-ear surgery: A doseranging study. Br J Anaesth 1998;80:764-6.
9. Fujii Y, Tanaka H, Kobayashi N. Granisetron/dexamethasone combination for the prevention of postoperative nausea and vomiting after thyroidectomy. Anaesth Intensive Care 2000;28:266-9.
10. Nolan J, Prosser DP. Prevention of postoperative vomiting with granisetron in paediatric patients with and without a history of motion sickness. Paediatr Anaesth 2000;10:451-2.
11. Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg 2000;90:472-5.
12. Fujii Y, Tanaka H, Kobayashi N. Prevention of nausea and vomiting after middle ear surgery: Granisetron versus ramosetron. Laryngoscopy 1999;109:1988-9.
13. Yarker YE, McTavich D. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs 1994;48:761-93.
14. Watcha MF, White PF. Postoperative nausea and vomiting: Its etiology, treatment, and prevention. Anesthesiology 1992;77:162-84.
15. Rowley MP, Brown TCK. Postoperative vomiting in children. Anaesth Intensive Care 1982;10:309-13.
16. Vance JP, Neil RS, Norris W. The incidence and aetiology of postoperative nausea and vomiting in a plastic surgical unit. Br J Plast Surg 1973;26:336-9.
17. Diamond MJ, Bailey D, McPhee A. The gender-dependent pharmacodynamic difference in the antiemetic action of metoclopramide is a dose-related phenomenon. Can J Anaesth 1988;35:s65.
18. Palazzo MGA, Strunin L: Anesthesia and emesis: I. Etiology. Can Anaesth Soc J 1984;31:178-87.
19. Gunawardene RD, White DC. Propofol and emesis. Anaesthesia 1988;43:(Suppl):65-7.
20. Forrest JB, Cahalan MK, Rehder K, et al. Multicenter study of general anesthesia: II. Results. Anesthesiology 1990;72:262-8.
21. Buell MG, Harding RK. Proinflammatory effects of local abdominal irritation on rat gastrointestinal tract. Dig Dis Sci 1989;34:390-9.
22. Sonner JM, Hynson JM, Clark O, Katz JA. Nausea and vomiting following thyroid and parathyroid surgery. J Clin Anesth 1997;9:398-402.
23. Andrews PLR, Bhandari P, Davey PT, et al. Are all 5HT3 receptor antagonists the same? Eur J Cancer 1992;28:S2-S6.
24. Vermorken JB, Pinedo HM. Gastrointestinal toxicity of cisdiaminedichloroplatinum. Nether J Med 1982;25:275-9.
25. Cubeddu LX, Hoffman IS, Fuenmayor NT, Finn AL. Efficacy of ondansetron and the role of serotonin in cisplatin induced nausea and vomiting. N Engl J Med 1990;322:810-6.
26. Gunning SJ, Hagan RM, Tyers MB. Cisplatin induced biochemical and histological changes in the small intestine of the ferret. Br J Pharmacol 1987;90:135.
27. Andrews PLR, Davis CJ, Bingham S, et al. The abdominal visceral innervation and the emetic reflex: Pathways, pharmacology and plasticity. Can J Physiol Pharmacol 1990;68:325-45.
28. Carmichael J, Cantwell BMJ, Edwards CM, et al. A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: Correlation with antiemetic response. Cancer Chemother Pharmacol 1989;24:45-9.